Implication of Pappalysins and Stanniocalcins in the Bioavailability of IGF-I in Children With Type 1 Diabetes Mellitus.

Maria Güemes Álvaro Martín-RivadaBeatriz CorredorPatricia EnesSandra Canelles Vicente Barrios-Sabador Jesús Argente

Published in: Journal of the Endocrine Society (2024)

Implementation of insulin treatment after T1DM onset modifies various components of the circulating IGF system, including PAPP-A2 and STC2. How these modifications modulate linear growth remains unknown.

Keyphrases

type diabetes
primary care
pi k akt
healthcare
binding protein
young adults
glycemic control
growth hormone
cell proliferation
skeletal muscle
combination therapy